Buscar
Mostrando ítems 1-10 de 172
Histopathology of the idiopathic interstitial pneumonias (IIP): A review
(Asian Pacific Society of Respirology, 2015)
The 2013 American Thoracic Society/European Respiratory Society consensus classification update of the idiopathic interstitial pneumonias (IIP) included several important modifications to the organization and spectrum of ...
Lymphatic fluctuation in the parenchymal remodeling stage of acute interstitial pneumonia, organizing pneumonia, nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis
(ASSOC BRAS DIVULG CIENTIFICASAO PAULO, 2012)
Because the superficial lymphatics in the lungs are distributed in the subpleural, interlobular and peribroncovascular interstitium, lymphatic impairment may occur in the lungs of patients with idiopathic interstitial ...
Small Airway Remodeling in Idiopathic Interstitial Pneumonias: A Pathological Study
(KARGER, 2010)
Background: Few studies have addressed small airway (SA) histopathological changes and their possible role in the remodeling process in idiopathic interstitial pneumonias. Objectives: To study morphological, morphometrical ...
Acute exacerbation of interstitial lung disease as a sequela of COVID-19 pneumonia
Interstitial lung disease (ILD) is a heterogeneous group of disorders characterized by
dyspnea and bilateral infiltrations of the lung. While some cases are idiopathic (e.g., idiopathic
pulmonary fibrosis), others are ...
Usual interstitial pneumonia and smoking-related interstitial fibrosis display epithelial to mesenchymal transition in fibroblastic foci
(W B Saunders Co Ltd, 2014-09-01)
Background: Fibroblastic foci (FF) are a major histological feature of usual interstitial pneumonia (UIP) in idiopathic pulmonary fibrosis (IPF) and collagen vascular diseases (non-IPF). In addition, FF are occasionally ...
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease
The diagnosis of coronavirus disease 2019 (COVID-19) relies on nasopharyngeal swab, which shows a 20–30% risk of false negativity [1]. Bronchoalveolar lavage (BAL) is reported to be useful in patients with pulmonary ...